Healix Infusion Therapy Inc is categorized under Rehabilitation Center, Outpatient Treatment in Austin, TX and active since 2012.
Healix Infusion Therapy Inc was established in 2012, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Rehabilitation Center, Outpatient Treatment business, which does work in the B2C market, and is classified as a Rehabilitation Center, Outpatient Treatment, under code number 6219992 by the NAICS.
If you are seeking more information, feel free to contact at the company’s single location by writing to 11111 Research Boulevard, Austin, Texas TX 78759 or by phoning (512) 502-0051. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Healix Infusion Therapy Inc |
| Address: | 11111 Research Boulevard, Austin, Texas 78759 |
| Phone Number: | (512) 502-0051 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2012 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Rehabilitation Center, Outpatient Treatment |
| SIC Code: | 8093 |
| NAICS Code: | 6219992 |
| Share This Business: |
Healix Infusion Therapy Inc was started in 2012 to provide professional Rehabilitation Center, Outpatient Treatment under the SIC code 8093 and NAICS code 6219992. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact for inquiries that concern Healix Infusion Therapy Inc by calling the company number (512) 502-0051, as your correspondence is most welcome. Additionally, the physical location of the single location of Healix Infusion Therapy Inc can be found at the coordinates 30.404819,-97.744946 as well as the street address 11111 Research Boulevard in Austin, Texas 78759.
For its online presence, you may visit Healix Infusion Therapy Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.